What Has Been the Progress and Growth of the Interventional Cardiology Devices And Equipment Market in Recent Years?
The interventional cardiology devices and equipment market has seen considerable growth due to a variety of factors.
• The market for interventional cardiology devices and equipment has experienced significant growth in the recent years. The market size is set to increase from $15.72 billion in 2024 to $17.29 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.0%.
Factors contributing to the growth during the historic period include user adoption, revenue from advertising, advancements in search algorithms, as well as the expansion of mobile internet.
What Is The Expected Growth In The Interventional Cardiology Devices And Equipment Market Size Evolve over the Forecast Period?
The interventional cardiology devices and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market for interventional cardiology devices and equipment is projected to experience substantial growth. The market value is predicted to reach $21.9 billion in 2029, expanding at a compound annual growth rate (CAGR) of 6.1%.
This growth over the forecast period is driven by factors such as voice search and AI assistants, semantic search, integration with e-commerce, as well as data privacy and regulation. Key trends to watch out for during this period include zero-click searches, vertical search engines, video search, and augmented reality in search.
What Main Forces Are Fueling Expansion In The Interventional Cardiology Devices And Equipment Market?
The escalation of cardiovascular health issues is projected to boost the expansion of the interventional cardiology devices and equipment market. These diseases, tied to heart, blood vessels, and circulatory system malfunctions, have increased due to unhealthy eating habits, inactive lifestyles, stress, smoking, and obesity. This surge in cardiovascular problems drives the demand for interventional cardiology devices, as more cardiac patients need sophisticated tools for less invasive treatments, contributing to market progression. For instance, official figures from the Australian Institute of Health and Welfare, a government agency in Australia, showed that in 2021, there were 14,100 medically-certified deaths caused by coronary heart disease (CHD). This figure rose to 14,900 in 2022. Thus, the rise in cardiovascular ailments is set to stimulate the growth of the interventional cardiology devices and equipment market in the future.
What Are The Primary Segments In The Global Interventional Cardiology Devices And Equipment Market?
The interventional cardiology devices and equipment market covered in this report is segmented –
1) By Type: Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Interventional Cardiology Devices
2) By Age Group: New-born (0-30 days), Infant (31 days-1 year), Children (1-18 years), Adult (18+ years)
3) By Application: Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centers
Subsegments:
1) By Angioplasty Balloons: Normal Balloons, Drug-Eluting Balloons, Cutting Balloons
2) By Angioplasty Stents: Bare-Metal Stents (BMS), Drug-Eluting Stents (DES), Bioabsorbable Stents
3) By Catheters: Guiding Catheters, Balloon Catheters, Angiography Catheters
4) By Plaque Modification Devices: Atherectomy Devices, Thrombectomy Devices
5) By Other Interventional Cardiology Devices: Guidewires, Vascular Closure Devices, Inflation Devices
Pre-Book The Interventional Cardiology Devices And Equipment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Interventional Cardiology Devices And Equipment Market?
The evolution of Interventional cardiology device technology is a dominant trend in the market. The progress includes state-of-the-art imaging procedures like Intravenous Ultrasound (IVUS), Fractional Flow Reserve (FFR), and Optical Coherence Tomography (OCT). For example, research released by the US CDC (Centers for Disease Control and Prevention) shows that the introduction of new medicinal treatments and devices, such as guidewires and stents, has drastically improved the approach to managing cardiovascular diseases, offering patients a longer and higher quality of life.
Who Are the Key Players In The Interventional Cardiology Devices And Equipment Market?
Major companies operating in the interventional cardiology devices and equipment market include:
• GE Healthcare
• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic Inc.
• Johnson & Johnson
• B. Braun Melsungen AG
• Biosensors International Ltd
• Novacam Technologies Inc.
• Cook Medical LLC
• Biotronik SE & Co. KG
• ACIST Medical Systems Inc.
• Cordis Corporation
• Terumo Corporation
• Edward Lifesciences Corporation
• Cardinal Health Inc.
• iVascular GmbH
• Becton Dickinson and Company
• Teleflex Incorporated
• Merit Medical Systems Inc.
• MicroPort Scientific Corporation
• Asahi Intecc Co. Ltd.
• AngioDynamics
• C. R. Bard Inc.
• Endologix Inc.
• Lombard Medical Limited
• Spectranetics Corporation
• Vascular Solutions Inc.
• W. L. Gore & Associates Inc.
• Cardiva Medical Inc.
• Cardiovascular Systems Inc.
• ClearStream Technologies Ltd.
• Contego Medical LLC
• Shockwave Medical Inc.
What Is The Most Dominant Region In The Interventional Cardiology Devices And Equipment Market?
North America was the largest region in the global interventional cardiology devices and equipment market in 2023. Western Europe was the second-largest region in the interventional cardiology devices and equipment market. The regions covered in the interventional cardiology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
